| NCT01871662 | Rottapharm | Hepatitis C, Chronic | 2013-08 | PHASE2|PHASE3 |
| NCT01639885 | Leiden University Medical Center|University Medical Center Groningen | Recurrent Ovarian Cancer | 2011-08 | PHASE1|PHASE2 |
| NCT00569127 | National Cancer Institute (NCI) | Colorectal Neuroendocrine Tumor G1|Gastric Neuroendocrine Tumor G1|Neuroendocrine Neoplasm|Neuroendocrine Tumor|Neuroendocrine Tumor G2 | 2007-12-01 | PHASE3 |
| NCT00000694 | National Institute of Allergy and Infectious Diseases (NIAID) | Sarcoma, Kaposi|HIV Infections | | PHASE1 |
| NCT00217373 | National Cancer Institute (NCI) | Adult Solid Neoplasm | 2005-06 | PHASE1 |
| NCT00176527 | University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI) | Prostate Cancer | 2002-11 | PHASE2 |
| NCT04093323 | Roswell Park Cancer Institute|National Cancer Institute (NCI) | HLA-A2 Positive Cells Present|Refractory Melanoma | 2024-11-13 | PHASE2 |
| NCT00919633 | Medtronic Corporate Technologies and New Ventures | Hepatitis C | 2009-06 | PHASE2 |
| NCT02151448 | David Bartlett|National Cancer Institute (NCI) | Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface|Malignant Peritoneal Mesothelioma|Peritoneal Carcinomatosis | 2014-07 | PHASE1|PHASE2 |
| NCT02339324 | Yana Najjar|Merck Sharp & Dohme LLC | Melanoma | 2015-03-06 | PHASE1 |
| NCT00265395 | Merck Sharp & Dohme LLC | Hepatitis C, Chronic | 2004-12 | PHASE3 |
| NCT00423800 | Merck Sharp & Dohme LLC | Hepatitis C, Chronic | 2006-12 | PHASE3 |
| NCT02185261 | Peking University People´s Hospital | Leukemia | 2014-06 | NA |
| NCT01460875 | William Carson|Schering-Plough | Stage IA Skin Melanoma|Stage IB Skin Melanoma|Stage IIA Skin Melanoma|Stage IIB Skin Melanoma|Stage IIC Skin Melanoma|Stage IIIA Skin Melanoma|Stage IIIB Skin Melanoma|Stage IIIC Skin Melanoma|Stage IV Skin Melanoma | 2008-04-22 | NA |
| NCT02174172 | Hoffmann-La Roche | Solid Cancers | 2014-08-18 | PHASE1 |
| NCT03547154 | Merck Sharp & Dohme LLC | Chronic Myelogenous Leukemia | 1998-10-22 | PHASE2|PHASE3 |
| NCT00708500 | Merck Sharp & Dohme LLC | Hepatitis C, Chronic | 2008-08 | PHASE3 |
| NCT00471484 | National Cancer Centre, Singapore | Liver Cancer | 2007-03 | PHASE2 |
| NCT00311558 | The Cleveland Clinic|National Cancer Institute (NCI) | Cancer | 2005-10 | PHASE1 |
| NCT00001114 | National Institute of Allergy and Infectious Diseases (NIAID)|Schering-Plough|Bristol-Myers Squibb | Sarcoma, Kaposi|HIV Infections | | PHASE2 |
| NCT00686777 | Merck Sharp & Dohme LLC | Hepatitis C, Chronic | 2008-01 | PHASE4 |
| NCT00493805 | Merck Sharp & Dohme LLC | Hepatitis C, Chronic|Insulin Resistance | 2007-04 | PHASE4 |
| NCT00237484 | Merck Sharp & Dohme LLC | Hepatitis C, Chronic | 2005-07-18 | PHASE3 |
| NCT04226950 | Institute of Hematology & Blood Diseases Hospital, China | Essential Thrombocytopenia | 2020-01-10 | PHASE2 |
| NCT00371761 | Merck Sharp & Dohme LLC | Hepatitis B, Chronic (CHB) | 2006-09 | PHASE3 |
| NCT00725751 | Merck Sharp & Dohme LLC | Hepatitis C, Chronic | 2007-09 | |
| NCT02506153 | National Cancer Institute (NCI) | Clinical Stage III Cutaneous Melanoma AJCC v8|Clinical Stage IV Cutaneous Melanoma AJCC v8|Metastatic Cutaneous Melanoma|Metastatic Mucosal Melanoma|Metastatic Non-Cutaneous Melanoma|Non-Cutaneous Melanoma|Recurrent Cutaneous Melanoma|Recurrent Mucosal Melanoma|Recurrent Non-Cutaneous Melanoma | 2015-11-10 | PHASE3 |
| NCT03537274 | Merck Sharp & Dohme LLC | Hepatitis C | 1997-08-05 | PHASE2|PHASE3 |
| NCT00230958 | Bausch Health Americas, Inc. | Chronic Hepatitis C | 2003-12 | PHASE3 |
| NCT00001035 | National Institute of Allergy and Infectious Diseases (NIAID)|Schering-Plough | HIV Infections|Hepatitis C | | PHASE1 |
| NCT03403634 | Roswell Park Cancer Institute|National Cancer Institute (NCI) | Metastatic Carcinoma in the Liver|Recurrent Colorectal Carcinoma|Stage IV Colorectal Cancer AJCC v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7 | 2018-04-19 | PHASE2 |
| NCT03599453 | Roswell Park Cancer Institute|AIM ImmunoTech Inc. | Triple -Negative Breast Cancer|Estrogen Receptor Negative|HER2+Neu Negative|Anatomic Stage IV Breast Cancer AJCC|Progesterone Receptor Negative | 2019-01-09 | EARLY_PHASE1 |
| NCT01274273 | University of Aarhus|Danish Renal Cancer Study Group | Metastatic Renal Cell Carcinoma | 2009-10 | PHASE2 |
| NCT04379518 | Roswell Park Cancer Institute|National Cancer Institute (NCI)|AIM ImmunoTech Inc. | Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Symptomatic COVID-19 Infection Laboratory-Confirmed | 2020-11-17 | PHASE1|PHASE2 |
| NCT06777173 | Beijing Ditan Hospital | Chronic Hepatitis b|Immunotherapy | 2023-12-01 | NA |
| NCT00002270 | University of Miami | HIV Infections|Leukoencephalopathy, Progressive Multifocal | | NA |
| NCT05395507 | Institute of Hematology & Blood Diseases Hospital, China | Essential Thrombocytopenia | 2022-06-01 | PHASE2 |
| NCT00125814 | French National Agency for Research on AIDS and Viral Hepatitis|Schering-Plough | HIV Infections | 2001-12 | PHASE3 |
| NCT01359956 | National Cancer Institute, Naples | Malignant Melanoma|Recurrent Melanoma | 2002-04 | PHASE3 |
| NCT01434212 | The First Hospital of Jilin University|Chinese Academy of Sciences | Hepatitis | 2010-05 | |
| NCT02199327 | Coordinación de Investigación en Salud, Mexico|Instituto Mexicano del Seguro Social|University of Guadalajara | Conjunctival Intraepithelial Neoplasia|Corneal Intraepithelial Neoplasia | 2014-05 | PHASE4 |
| NCT04081389 | Roswell Park Cancer Institute|National Center for Advancing Translational Sciences (NCATS) | Anatomic Stage 0 Breast Cancer AJCC v8|Anatomic Stage I Breast Cancer AJCC v8|Anatomic Stage IA Breast Cancer AJCC v8|Anatomic Stage IB Breast Cancer AJCC v8|Anatomic Stage II Breast Cancer AJCC v8|Anatomic Stage IIA Breast Cancer AJCC v8|Anatomic Stage IIB Breast Cancer AJCC v8|Early-Stage Breast Carcinoma|Estrogen Receptor Negative|HER2+Neu Negative|Progesterone Receptor Negative|Prognostic Stage 0 Breast Cancer AJCC v8|Prognostic Stage I Breast Cancer AJCC v8|Prognostic Stage IA Breast Cancer AJCC v8|Prognostic Stage IB Breast Cancer AJCC v8|Prognostic Stage II Breast Cancer AJCC v8|Prognostic Stage IIA Breast Cancer AJCC v8|Prognostic Stage IIB Breast Cancer AJCC v8|Triple-Negative Breast Carcinoma | 2019-12-06 | PHASE1 |
| NCT00217542 | National Cancer Institute (NCI) | Recurrent Melanoma|Recurrent Renal Cell Cancer|Stage III Melanoma|Stage IV Melanoma|Stage IV Renal Cell Cancer | 2005-07 | PHASE1 |
| NCT00539591 | St. Jude Children´s Research Hospital|Schering-Plough | Malignant Melanoma | 2008-05-09 | PHASE2 |
| NCT00411385 | Human Genome Sciences Inc.|Novartis | Chronic Hepatitis C | 2007-02 | PHASE3 |
| NCT01409174 | M.D. Anderson Cancer Center|Bristol-Myers Squibb | Melanoma | 2013-02 | PHASE1 |
| NCT00126594 | National Cancer Institute (NCI)|M.D. Anderson Cancer Center | Clear Cell Renal Cell Carcinoma|Recurrent Renal Cell Carcinoma|Stage IV Renal Cell Cancer | 2005-06 | PHASE2 |
| NCT01217359 | University of North Carolina, Chapel Hill|Tibotec Pharmaceutical Limited | Hepatitis C | 2010-05 | PHASE1 |
| NCT03899987 | Roswell Park Cancer Institute|AIM ImmunoTech Inc. | Prostate Adenocarcinoma|Stage I Prostate Cancer AJCC v8|Stage II Prostate Cancer AJCC v8|Stage IIA Prostate Cancer AJCC v8|Stage IIB Prostate Cancer AJCC v8|Stage IIC Prostate Cancer AJCC v8|Stage III Prostate Cancer AJCC v8|Stage IIIA Prostate Cancer AJCC v8|Stage IIIB Prostate Cancer AJCC v8|Stage IIIC Prostate Cancer AJCC v8 | 2019-11-29 | PHASE2 |
| NCT02360592 | Tongji Hospital|Beijing Kawin Technology Share-Holding Co., Ltd.|Fujian Cosunter Pharmaceutical Co. Ltd | Hepatitis B, Chronic | 2013-06 | PHASE4 |
| NCT00498979 | Case Comprehensive Cancer Center|National Cancer Institute (NCI) | Stage IV Melanoma | 2007-05 | PHASE1 |
| NCT01274338 | National Cancer Institute (NCI) | Melanoma of Unknown Primary|Recurrent Melanoma|Stage IIIB Cutaneous Melanoma AJCC v7|Stage IIIC Cutaneous Melanoma AJCC v7|Stage IV Cutaneous Melanoma AJCC v6 and v7 | 2011-06-17 | PHASE3 |
| NCT00624325 | Foundation for Liver Research | Chronic Hepatitis C | 2007-07 | PHASE2|PHASE3 |
| NCT03833362 | R-Pharm | Hepatitis C | 2014-05-07 | PHASE3 |
| NCT01100528 | Case Comprehensive Cancer Center | Ciliary Body and Choroid Melanoma, Medium+Large Size|Ciliary Body and Choroid Melanoma, Small Size|Iris Melanoma|Recurrent Intraocular Melanoma | 2009-11-11 | PHASE2 |
| NCT01463592 | MTI Medical Private Limited, Pakistan | Hepatitis C, Chronic | 2010-06 | PHASE3 |
| NCT01710501 | Merck Sharp & Dohme LLC | Chronic Hepatitis C (CHC) | 2012-12-07 | PHASE2 |
| NCT00003641 | ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI)|SWOG Cancer Research Network|Cancer and Leukemia Group B|NCIC Clinical Trials Group|Children´s Oncology Group | Melanoma (Skin) | 1999-03-25 | PHASE3 |
| NCT03554005 | Merck Sharp & Dohme LLC | Neoplasms | 1997-12-29 | PHASE1 |
| NCT01462773 | Ohio State University Comprehensive Cancer Center | Melanoma | 2006-01 | PHASE1 |
| NCT00279565 | Indivior Inc.|AESCA Pharma GmbH | Hepatitis C, Chronic | 2005-08 | PHASE4 |
| NCT00378599 | Merck Sharp & Dohme LLC | Liver Transplantation|Hepatitis C, Chronic|Liver Cirrhosis | 2006-05 | PHASE3 |
| NCT02323659 | Polish Lymphoma Research Group | Lymphoma, T-Cell, Cutaneous|Mycosis Fungoides | 2014-06-01 | PHASE4 |
| NCT02168361 | Center For Hepatitis C, Atlanta, GA | Chronic Hepatitis C | 2013-12 | PHASE4 |
| NCT00686517 | Merck Sharp & Dohme LLC|Bioikos Ambiente Srl | Hepatitis C | 2003-12 | PHASE3 |
| NCT01708941 | National Cancer Institute (NCI) | Recurrent Melanoma|Stage IIIA Cutaneous Melanoma AJCC v7|Stage IIIB Cutaneous Melanoma AJCC v7|Stage IIIC Cutaneous Melanoma AJCC v7|Stage IV Cutaneous Melanoma AJCC v6 and v7 | 2013-01-18 | PHASE2 |
| NCT02155322 | Merck Sharp & Dohme LLC | Melanoma | 2014-08-19 | PHASE2 |
| NCT02568241 | Peking University People´s Hospital | Leukemia | 2015-12 | PHASE1|PHASE2 |
| NCT07445893 | Duan Minghui | Polycythemia Vera (PV) | 2026-02-24 | NA |
| NCT00963664 | NeoPlas Innovation | Melanoma|Malignant Melanoma | 2009-12 | PHASE2 |
| NCT01158534 | Case Comprehensive Cancer Center | Renal Cell Cancer|Stage IV Renal Cell Cancer | 2006-03 | PHASE2 |
| NCT00002556 | National Cancer Institute (NCI) | Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple Myeloma | 1994-07 | PHASE3 |
| NCT00101114 | National Cancer Institute (NCI) | Clear Cell Renal Cell Carcinoma|Recurrent Renal Cell Cancer|Stage III Renal Cell Cancer|Stage IV Renal Cell Cancer | 2004-09 | PHASE2 |
| NCT00059358 | National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections|Hepatitis C | 2001-09 | PHASE1|PHASE2 |
| NCT00398450 | University of California, San Diego|National Cancer Institute (NCI) | Melanoma (Skin) | 2006-02 | PHASE1 |
| NCT01943422 | John Kirkwood|Merck Sharp & Dohme LLC | Melanoma | 2013-10 | PHASE1 |
| NCT00561912 | M.D. Anderson Cancer Center|Eisai Inc. | Renal Cell Carcinoma | 2007-10 | PHASE2 |